David S. Lynch

David S. Lynch

Auto-generated profile, based on publicly available information

David S. Lynch

Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology and NIHR University College London Hospitals Biomedical Research Centre , London WC1N 3BG

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 November 2018 in Journal of Neurology, Neurosurgery & Psychiatry
Verified
Journal Article
Open access
PDF file
DLDavid S Lynch
David S Lynch
CWCharles Wade
Charles Wade
APAnderson Rodrigues Brandão de Paiva
Anderson Rodrigues Brandão de Paiva
NJNevin John
Nevin John
JKJustin A Kinsella
Justin A Kinsella
JCJeremy Chataway
Jeremy Chataway
Adult-onset leukodystrophies and genetic leukoencephalopathies comprise a diverse group of neurodegenerative disorders of white matter with a wide age of onset and phenotypic spectrum. Patients with white matter abnormalities detected on MRI often present a diagnostic challenge to both general and specialist neurologists. Patients typically present with a progressive syndrome including various combinations of cognitive impairment, movement disorders, ataxia and upper motor neuron signs. There are a number of important and treatable acquired causes for this imaging and clinical presentation. There are also a very large number of genetic causes which due to their relative rarity and sometimes variable and overlapping presentations can be difficult to diagnose. In this review, we provide a structured approach to the diagnosis of inherited disorders of white matter in adults. We describe clinical and radiological clues to aid diagnosis, and we present an overview of both common and rare genetic white matter disorders. We provide advice on testing for acquired causes, on excluding small vessel disease mimics, and detailed advice on metabolic and genetic testing available to the practising neurologist. Common genetic leukoencephalopathies discussed in detail includeCSF1R,AARS2, cerebral arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL), and mitochondrial and metabolic disorders.

2 March 2017 in Brain
Verified
Journal Article
Open access
PDF file
DLDavid S. Lynch
David S. Lynch
APAnderson Rodrigues Brandão de Paiva
Anderson Rodrigues Brandão de Paiva
WZWei Jia Zhang
Wei Jia Zhang
Enrico BugiardiniEnrico Bugiardini
Enrico Bugiardini
FFFernando Freua
Fernando Freua
HHHenry Houlden
Henry Houlden
Leukodystrophies and genetic leukoencephalopathies are a rare group of disorders leading to progressive degeneration of cerebral white matter. They are associated with a spectrum of clinical phenotypes dominated by dementia, psychiatric changes, movement disorders and upper motor neuron signs. Mutations in at least 60 genes can lead to leukoencephalopathy with often overlapping clinical and radiological presentations. For these reasons, patients with genetic leukoencephalopathies often endure a long diagnostic odyssey before receiving a definitive diagnosis or may receive no diagnosis at all. In this study, we used focused and whole exome sequencing to evaluate a cohort of undiagnosed adult patients referred to a specialist leukoencephalopathy service. In total, 100 patients were evaluated using focused exome sequencing of 6100 genes. We detected pathogenic or likely pathogenic variants in 26 cases. The most frequently mutated genes were NOTCH3, EIF2B5, AARS2 and CSF1R. We then carried out whole exome sequencing on the remaining negative cases including four family trios, but could not identify any further potentially disease-causing mutations, confirming the equivalence of focused and whole exome sequencing in the diagnosis of genetic leukoencephalopathies. Here we provide an overview of the clinical and genetic features of these disorders in adults.

2 May 2015 in Journal of Neurology, Neurosurgery & Psychiatry
Verified
Journal Article
Open access
PDF file
DLDavid S Lynch
David S Lynch
ZJZane Jaunmuktane
Zane Jaunmuktane
USUna-Marie Sheerin
Una-Marie Sheerin
RPRahul Phadke
Rahul Phadke
SBSebastian Brandner
Sebastian Brandner
HHHenry Houlden
Henry Houlden
Background Hereditary diffuse leukoencephalopathy with neuroaxonal spheroids (HDLS) is a hereditary, adult onset leukodystrophy which is characterised by the presence of axonal loss, axonal spheroids and variably present pigmented macrophages on pathological examination. It most frequently presents in adulthood with dementia and personality change. HDLS has recently been found to be caused by mutations in the colony stimulating factor-1 receptor (CSF1R) gene. Methods In this study, we sequenced the CSF1R gene in a cohort of 48 patients from the UK, Greece and Ireland with adult onset leukodystrophy of unknown cause. Results Five pathogenic mutations were found, including three novel mutations. The presentations ranged from suspected central nervous system (CNS) vasculitis to extrapyramidal to cognitive phenotypes. The case histories and imaging are presented here, in addition to neuropathological findings from two cases with novel mutations. Conclusion We estimate that CSF1R mutations account for 10% of idiopathic adult onset leukodystrophies and that genetic testing for CSF1R mutations is essential in adult patients presenting with undefined CNS vasculitis or a leukodystrophy with prominent neuropsychiatric signs or dementia.

16 September 2015 in European Journal of Human Genetics
Verified
Journal Article
Closed access
DLDavid S Lynch
David S Lynch
GKGeorgios Koutsis
Georgios Koutsis
ATArianna Tucci
Arianna Tucci
MPMarios Panas
Marios Panas
MBMarkella Baklou
Markella Baklou
HHHenry Houlden
Henry Houlden

1 August 2018 in Brain
Verified
Journal Article
Open access
PDF file
JGJuliana Gurgel-Giannetti
Juliana Gurgel-Giannetti
DLDavid S Lynch
David S Lynch
APAnderson Rodrigues Brandão de Paiva
Anderson Rodrigues Brandão de Paiva
LLLeandro Tavares Lucato
Leandro Tavares Lucato
GYGuilherme Yamamoto
Guilherme Yamamoto
FKFernando Kok
Fernando Kok
Defects in iron–sulphur [Fe-S] cluster biogenesis are increasingly recognized as causing neurological disease. Mutations in a number of genes that encode proteins involved in mitochondrial [Fe-S] protein assembly lead to complex neurological phenotypes. One class of proteins essential in the early cluster assembly are ferredoxins. FDX2 is ubiquitously expressed and is essential in the de novo formation of [2Fe-2S] clusters in humans. We describe and genetically define a novel complex neurological syndrome identified in two Brazilian families, with a novel homozygous mutation in FDX2. Patients were clinically evaluated, underwent MRI, nerve conduction studies, EMG and muscle biopsy. To define the genetic aetiology, a combination of homozygosity mapping and whole exome sequencing was performed. We identified six patients from two apparently unrelated families with autosomal recessive inheritance of a complex neurological phenotype involving optic atrophy and nystagmus developing by age 3, followed by myopathy and recurrent episodes of cramps, myalgia and muscle weakness in the first or second decade of life. Sensory-motor axonal neuropathy led to progressive distal weakness. MRI disclosed a reversible or partially reversible leukoencephalopathy. Muscle biopsy demonstrated an unusual pattern of regional succinate dehydrogenase and cytochrome c oxidase deficiency with iron accumulation. The phenotype was mapped in both families to the same homozygous missense mutation in FDX2 (c.431C > T, p.P144L). The deleterious effect of the mutation was validated by real-time reverse transcription polymerase chain reaction and western blot analysis, which demonstrated normal expression of FDX2 mRNA but severely reduced expression of FDX2 protein in muscle tissue. This study describes a novel complex neurological phenotype with unusual MRI and muscle biopsy features, conclusively mapped to a mutation in FDX2, which encodes a ubiquitously expressed mitochondrial ferredoxin essential for early [Fe-S] cluster biogenesis.

1 October 2017 in Neurology Genetics
Verified
Journal Article
Open access
PDF file
DLDavid S. Lynch
David S. Lynch
SLSamantha H.Y. Loh
Samantha H.Y. Loh
JHJasmine Harley
Jasmine Harley
ANAlastair J. Noyce
Alastair J. Noyce
LML. Miguel Martins
L. Miguel Martins
HPHelene Plun-Favreau
Helene Plun-Favreau